Exact Mass: 560.3716
Exact Mass Matches: 560.3716
Found 60 metabolites which its exact mass value is equals to given mass value 560.3716,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Vitamin D3 glucosiduronate
6-[(3-{2-[7a-methyl-1-(6-methylheptan-2-yl)-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
(2R)-2-hydroxy-3-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
(2S)-2-hydroxy-3-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
(2S)-3-hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
(2R)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
(2S)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
2, 16, 18-Tri-Ac-(1alpha, 3beta, 11alpha)-Cholest-5-ene-2, 3, 16, 18-tetrol, 9CI
2, 16, 18-Tri-Ac-(1alpha, 3beta, 11alpha)-Cholest-5-ene-2, 3, 16, 18-tetrol, 9CI
Ecdysterone 2,3:20,22-diacetonide
20-Hydroxyecdysone 2,3:20,22-diacetonide
Origin: Plant; SubCategory_DNP: The sterols, Cholestanes
7, 15, 18-Tri-Ac-(3alpha, 7beta, 15beta)-Cholest-5-ene-3, 7, 15, 18-tetrol, 9CI
7, 15, 18-Tri-Ac-(3alpha, 7beta, 15beta)-Cholest-5-ene-3, 7, 15, 18-tetrol, 9CI
12alpha-acetoxy-16beta-(3-hydroxybutanoyloxy)-13beta,18beta-cyclobutan-20,24-dimethyl-24-oxoscalaran-25-ol
12alpha-acetoxy-16beta-(3-hydroxybutanoyloxy)-13beta,18beta-cyclobutan-20,24-dimethyl-24-oxoscalaran-25-ol
(E)-3beta-hydroxy-15beta-O-(beta-D-xylopyranosyl)-ergosta-5,22-dien-16-one|acanthifolioside A
(E)-3beta-hydroxy-15beta-O-(beta-D-xylopyranosyl)-ergosta-5,22-dien-16-one|acanthifolioside A
7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J
7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J
24-epi-pterosterone 2,3:20,22-diacetonide|24-epipterosterone-2,3,20,22-diacetonide
24-epi-pterosterone 2,3:20,22-diacetonide|24-epipterosterone-2,3,20,22-diacetonide
ajugasterone C 2,3;20,22-diacetonide|ajugasterone C-2,3,20,22-diacetonide
ajugasterone C 2,3;20,22-diacetonide|ajugasterone C-2,3,20,22-diacetonide
12alpha-acetoxy-16beta-(3R-hydroxybutanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al
12alpha-acetoxy-16beta-(3R-hydroxybutanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al
3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene
3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene
Cholcalciferyl-β-D-glucopyranosid-uronsaeure
6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl 3-hydroxybutanoate
3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl 3-hydroxybutanoate
(2r,3r,4s,5s)-2-[(1s,3as,3br,5as,9as,9bs,11as)-9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-hydroxy-4,5,6-trimethylheptan-3-yl acetate
(2r,3r,4s,5s)-2-[(1s,3as,3br,5as,9as,9bs,11as)-9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-hydroxy-4,5,6-trimethylheptan-3-yl acetate
methyl 10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl 10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
14-hydroxy-17-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
14-hydroxy-17-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
(1r,2s,3s,4r)-1-[(1s,3's,3as,3br,5as,9as,9bs,11as)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate
(1r,2s,3s,4r)-1-[(1s,3's,3as,3br,5as,9as,9bs,11as)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate
(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3r)-3-hydroxybutanoate
(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3r)-3-hydroxybutanoate
methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl 3-hydroxybutanoate
2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl 3-hydroxybutanoate
(3r,4ar,6ar,6bs,8ar,9r,10r,11s,12as,14ar,14br)-9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(3r,4ar,6ar,6bs,8ar,9r,10r,11s,12as,14ar,14br)-9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2-hydroxy-2,3,4-trimethylpentyl acetate
5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2-hydroxy-2,3,4-trimethylpentyl acetate
methyl (1s,2s,4as,4br,6as,9r,10r,10ar,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl (1s,2s,4as,4br,6as,9r,10r,10ar,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
(2r,2as,3s,4s,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl (3s)-3-hydroxybutanoate
(2r,2as,3s,4s,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl (3s)-3-hydroxybutanoate
6-{9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-(acetyloxy)-6-hydroxy-2,3,4-trimethylheptan-2-yl acetate
6-{9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-(acetyloxy)-6-hydroxy-2,3,4-trimethylheptan-2-yl acetate
(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate
(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate
1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
5-(acetyloxy)-5-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate
5-(acetyloxy)-5-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate
9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol
(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate
(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate
(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
